The diagnosis of C9orf72-related ALS/FTD is established by detection of a heterozygous pathogenic GGGGCC (G4C2) hexanucleotide repeat expansion in C9orf72 on molecular genetic testing [23–26]. Here, C9orf72 is linked to frontotemporal dementia.